Clinical Trials Directory

Trials / Completed

CompletedNCT00895843

Protective Analgesia for Postoperative Pain Relief Following Day Case Oral Surgery

Protective Analgesia Using Bupivacaine and Conventional Release Ibuprofen Versus Bupivacaine and Sustained Release Ibuprofen for Postoperative Pain Relief in Patients Undergoing Third Molar Surgery: a Randomised Controlled Trial

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
122 (actual)
Sponsor
University of Manchester · Academic / Other
Sex
All
Age
18 Years – 65 Years
Healthy volunteers
Accepted

Summary

The purpose of this study is to investigate whether robust analgesic regime (protective analgesia) can improve postoperative pain experience for patients undergoing lower wisdom teeth extraction under day case general anaesthetic.

Detailed description

The aim of the study was to demonstrate and improve postoperative pain experience using protective analgesia for patients undergoing oral surgery under day case general anaesthesia. The primary objective was to investigate the efficiency of protective analgesia using combined effects of sustained release ibuprofen and bupivacaine nerve block in attenuation of postoperative pain following impacted third molar surgery under day case general anaesthesia. The secondary objective was to document the safety and tolerability profile of conventional release versus sustained released ibuprofen with bupivacaine block in subjects undergoing impacted third molar surgery under day case general anaesthesia.

Conditions

Interventions

TypeNameDescription
DRUGBrufen retardSingle dose 2 x 800mg tablets 2 hours prior to surgery
DRUGibuprofenSingle dose ibuprofen 2 x 200mg tablets 2 hours prior to surgery
DRUGBupivacaineUp to 10ml of Bupivacaine 0.5% with 1:200,000 Adrenaline given prior to surgical incision as inferior alveolar nerve block and long buccal nerve infiltration.

Timeline

Start date
2006-11-01
Primary completion
2007-12-01
Completion
2008-01-01
First posted
2009-05-08
Last updated
2009-06-01
Results posted
2009-05-08

Locations

2 sites across 1 country: United Kingdom

Source: ClinicalTrials.gov record NCT00895843. Inclusion in this directory is not an endorsement.